Individuals with germline mutations in the BRCA1/2 genes are at a higher risk in developing various types of cancers, including cancers of the breast, ovary, pancreas, and prostate (Couch et al., 2014; King, 2014). This evidence concerns the gene BRCA1 and breast cancer.